Related Experiment Videos
Adjuvant activity of CpG oligodeoxynucleotides.
1Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, USA. klinman@cber.fda.gov
International Reviews of Immunology
|July 5, 2006
Summary
Synthetic oligodeoxynucleotides (ODNs) with CpG motifs act as immune adjuvants, significantly boosting immune responses. Clinical studies show CpG ODNs are safe and enhance vaccine effectiveness in humans.
Area of Science:
- Immunology
- Molecular Biology
- Vaccinology
Background:
- Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs are known to activate immune cells.
- CpG motifs in bacterial DNA are implicated in the immunogenicity of DNA vaccines.
Purpose of the Study:
- To investigate the immune-stimulating properties of synthetic CpG ODNs.
- To evaluate their potential as immune adjuvants and their impact on vaccine responses.
Main Methods:
- Treatment of human B cells and plasmacytoid dendritic cells (pDCs) with synthetic CpG ODNs.
- Assessment of cytokine production and antigen-presenting cell maturation.
- Analysis of antigen-specific immune responses and clinical safety data.
Main Results:
- CpG ODNs directly stimulate B cells and pDCs, promoting Th1 and proinflammatory cytokine production.
- CpG ODNs enhance the maturation and activation of antigen-presenting cells.
- CpG ODNs act as potent immune adjuvants, increasing antigen-specific immune responses 5- to 500-fold.
Conclusions:
- Synthetic CpG ODNs are effective immune adjuvants that significantly enhance immune responses.
- CpG ODNs are safe and well-tolerated in humans, improving vaccine-induced immunity.
- CpG motifs may play a crucial role in the immunogenicity of DNA vaccines.